Deutsche Bank
ADCT icon

Deutsche Bank’s ADC Therapeutics ADCT Stock Holding History

Deutsche Bank’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$301K Buy
80,205
+9,431
+13% +$37.2K ﹤0.01% 2828
2025
Q4 		$250K Sell
70,774
-6,750
-9% -$27.4K ﹤0.01% 2914
2025
Q3 		$310K Buy
77,524
+21,462
+38% +$67.7K ﹤0.01% 2828
2025
Q2 		$150K Hold
56,062
– – ﹤0.01% 3096
2025
Q1 		$79K Hold
56,062
– – ﹤0.01% 3268
2024
Q4 		$112K Buy
56,062
+16,217
+41% +$42.4K ﹤0.01% 3262
2024
Q3 		$126K Buy
39,845
+95
+0.2% +$300 ﹤0.01% 3142
2024
Q2 		$126K Buy
+39,750
New +$158K ﹤0.01% 3035
2021
Q4 		– Sell
-300
Closed -$8K – 4235
2021
Q3 		$8K Buy
+300
New +$7.68K ﹤0.01% 4300

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return